OurMind raises €2.4M seed to cut healthcare burnout with AI
What's the deal? Amsterdam-based OurMindDealroom has a profile for this one. Try Dealroom → has raised €2.1 million in seed funding to scale its AI platform that automates administrative work for healthcare professionals. The round was led by 4impact capitalDealroom has a profile for this one. Try Dealroom →, a firm that typically backs software companies in energy, sustainability, and digitalisation — making this its first healthtech bet.
OurMind was founded by Paul Koning, a former orthopaedic surgeon. Its core product, Notes, converts consultation conversations into medical documentation, freeing doctors from hours of paperwork.
More than 300 general practices and 14 hospitals already use the platform, which is expanding into consultation preparation, administrative support, and patient communication.
Why now? Healthcare systems across the Netherlands are under severe strain. Waiting lists are growing, doctors are working overtime, and a quarter of young doctors show burnout symptoms, according to a study by De Jonge Specialist. The administrative burden is a key driver — cardiologist Bart Driesen of Maasziekenhuis Pantein says doctors spend two to three hours a day preparing consultations, often at home in the evening.
"This is not about AI, but about how we can continue to deliver good care with the same number of people," Koning said.
What could go wrong? AI-generated medical documentation must be highly accurate — errors could compromise patient safety. Scaling across hospitals with different systems and workflows adds complexity. And convincing risk-averse hospital boards to adopt AI tools at speed remains a challenge, even as the cost of inaction mounts.
The signal: OurMind remains early stage, yet it already counts more than 300 GP practices and 14 hospitals as users — notable traction for a seed-round company in a sector where procurement cycles are notoriously slow. With 4impact capital, a corporate investor historically focused on energy and sustainability software, making its first healthtech move, the round suggests that AI-driven clinical workflow tools are crossing over from niche to investable category in the European market.
Read more: IO+
